Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Highleyman

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
U.S. AIDS death rate decreases by nearly halfL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Amprenavir: a new protease inhibitor nears approvalL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
New dosing of ddI (Videx) and Nelfinavir (Viracept) approvedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
First AIDS case in 1969L Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
HepatitisL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Abacavir expanded access widenedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Efavirenz expanded access broadenedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
TuberculosisL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Ritonavir manufacturing problemsL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Protease inhibitors may be associated with premature birthsL Highleyman
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
U.S. AIDS death rate decreases by nearly halfL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Amprenavir: a new protease inhibitor nears approvalL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
New dosing of ddI (Videx) and Nelfinavir (Viracept) approvedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
First AIDS case in 1969L Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
HepatitisL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Abacavir expanded access widenedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Efavirenz expanded access broadenedL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
TuberculosisL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Ritonavir manufacturing problemsL Highleyman
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Protease inhibitors may be associated with premature birthsL Highleyman
Pageof 6